Cheung K, Fanti S, Mauro C, Wang G, Nair A, Fu H, et al. Preservation of microvascular barrier function requires CD31 receptor-induced metabolic reprogramming. Nat Commun. 2020;11:3595 pubmed publisher

Barthélémy F, Wang R, Hsu C, Douine E, Marcantonio E, Nelson S, et al. Targeting RyR Activity Boosts Antisense Exon 44 and 45 Skipping in Human DMD Skeletal or Cardiac Muscle Culture Models. Mol Ther Nucleic Acids. 2019;18:580-589 pubmed publisher

Krovi S, Kappler J, Marrack P, Gapin L. Inherent reactivity of unselected TCR repertoires to peptide-MHC molecules. Proc Natl Acad Sci U S A. 2019;116:22252-22261 pubmed publisher

Wosen J, Ilstad Minnihan A, Co J, Jiang W, Mukhopadhyay D, Fernandez Becker N, et al. Human Intestinal Enteroids Model MHC-II in the Gut Epithelium. Front Immunol. 2019;10:1970 pubmed publisher

Serwas N, Hoeger B, Ardy R, Stulz S, Sui Z, Memaran N, et al. Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis. Nat Commun. 2019;10:3106 pubmed publisher

Lever J, Hull T, Boddu R, Pepin M, Black L, Adedoyin O, et al. Resident macrophages reprogram toward a developmental state after acute kidney injury. JCI Insight. 2019;4: pubmed publisher

Alvaro Benito M, Morrison E, Ebner F, Abualrous E, Urbicht M, Wieczorek M, et al. Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation. Cell Mol Immunol. 2018;: pubmed publisher

Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher

Heger L, Balk S, Lühr J, Heidkamp G, Lehmann C, Hatscher L, et al. CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion. Front Immunol. 2018;9:744 pubmed publisher

Nelde A, Kowalewski D, Backert L, Schuster H, Werner J, Klein R, et al. HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy. Oncoimmunology. 2018;7:e1316438 pubmed publisher

Hutt M, Fellermeier Kopf S, Seifert O, Schmitt L, Pfizenmaier K, Kontermann R. Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells. Oncotarget. 2018;9:11322-11335 pubmed publisher

Woo C, Lund P, Huang A, Davis M, Bertozzi C, Pitteri S. Mapping and Quantification of Over 2000 O-linked Glycopeptides in Activated Human T Cells with Isotope-Targeted Glycoproteomics (Isotag). Mol Cell Proteomics. 2018;17:764-775 pubmed publisher

Jones N, Cronin J, Dolton G, Panetti S, Schauenburg A, Galloway S, et al. Metabolic Adaptation of Human CD4+ and CD8+ T-Cells to T-Cell Receptor-Mediated Stimulation. Front Immunol. 2017;8:1516 pubmed publisher

Nakajima N, Niimi A, Isono M, Oike T, Sato H, Nakano T, et al. Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells. Oncol Rep. 2017;38:693-702 pubmed publisher

Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher

Ohno Y, Hattori A, Yoshiki T, Kakeya H. Association of epigenetic alterations in the human C7orf24 gene with the aberrant gene expression in malignant cells. J Biochem. 2013;154:355-62 pubmed publisher

Podolin P, Bolognese B, Carpenter D, Davis T, Johanson R, Fox J, et al. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitor. J Immunol. 2008;180:7989-8003 pubmed